Alessandro de Alarcon · Airway plaque presenting after alteration of immunosuppression in a pediatric patient remote from heart transplantation
Follow
Article1 min read·Published Aug 2017Older

Airway plaque presenting after alteration of immunosuppression in a pediatric patient remote from heart transplantation

pubmed.ncbi.nlm.nih.gov shows its articles on its own site.

Read the article on pubmed.ncbi.nlm.nih.gov ↗

Article · Aug 2017 · 1 min read

In brief

In brief

Case report of a 9-year-old heart transplant recipient who developed airway plaque following transition to sirolimus-based immunosuppression. The presentation highlights the diagnostic challenge of distinguishing between medication side effects, opportunistic infection, and malignancy in immunosuppressed pediatric patients.

Written by the GCMD Library team from the article.

Alessandro de Alarcon

Success after solid organ transplantation is dependent on the proper balance of immunosuppression to prevent rejection of the allograft while limiting the risk of developing infections and malignancy. We present a 9-year-old girl, remote from transplant, who presented with airway plaque after a change in immunosuppression to include the mTOR inhibitor sirolimus. Differential diagnosis included direct medication side effect, infection, and neoplasia.

Read it at the source ↗

Try
Intelligent Search· scoped to this article · not medical adviceSearch the whole library →